- Home
- A-Z Publications
- Medicinal Chemistry
- Previous Issues
- Volume 18, Issue 8, 2022
Medicinal Chemistry - Volume 18, Issue 8, 2022
Volume 18, Issue 8, 2022
-
-
Pyrazole Containing Anti-HIV Agents: An Update
Authors: Sanjay Kumar, Shiv Gupta, Varsha Rani and Priyanka SharmaBackground: Pyrazole scaffolds have gained importance in drug discovery and development for various pharmacological activities like antiviral, antifungal, anticancer, antidepressant, antiinflammatory, antibacterial, etc. Additionally, the pyrazole moiety has shown potent anti-HIV activity as a core heterocycle or substituted heterocycles derivatives (mono, di, tri, tetra, and fused pyrazole derivatives). To assist the development Read More
-
-
-
Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery
By Sujit MahatoThe ongoing pandemic of Covid-19 caused by SARS-CoV-2 is a major threat to global public health, drawing attention to develop new therapeutics for treatment. Much research work is focused on identifying or repurposing new small molecules to serve as potential inhibitors by interacting with viral or host-cell molecular targets and understanding the nature of the virus in the host cells. Identifying small molecules as potent inhib Read More
-
-
-
Styrylquinolines Derivatives: SAR Study and Synthetic Approaches
Authors: Monika Saini, Rina Das, Dinesh K. Mehta and Samrat ChauhanIn the present-day scenario, heterocyclic derivatives have revealed the primary function of various medicinal agents precious for humanity. Out of a diverse range of heterocycles, Styrylquinolines scaffolds have been proved to play an essential role in a broad range of biological activities, including anti-HIV-1, antimicrobial, anti-inflammatory, anti-Alzheimer activity with antiproliferative effects on tumor cell lines. Due to the Read More
-
-
-
Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti- COVID-19 Treatments
Authors: Safa Daoud and Mutasem TahaBackground: Chemokines are involved in several human diseases and different stages of COVID-19 infection. They play a critical role in the pathophysiology of the associated acute respiratory disease syndrome, a major complication leading to death among COVID-19 patients. In particular, CXC chemokine receptor 4 (CXCR4) was found to be highly expressed in COVID-19 patients. Methods: We herein describe a c Read More
-
-
-
Research Advancements on Fluorinated and Non-Fluorinated 4- Phenyl(thio)ureido-Substituted 2,2-Dimethylchromans Acting as Inhibitors of Insulin Release and Smooth Muscle Relaxants
Authors: Bernard Pirotte, Xavier Florence, Eric Goffin, Fabienne Leleux and Philippe LebrunAims: The present study aimed at characterizing the impact of the presence or absence of fluorine atoms on the phenyl and benzopyran rings of 4-phenyl(thio)ureido-substituted 2,2- dimethylchromans on their ability to inhibit insulin release from pancreatic β-cells or to relax vascular smooth muscle cells. Methods: Most compounds were found to inhibit insulin secretion and to provoke a marked myorelaxant activity. Results: Th Read More
-
-
-
Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containing Biguanide Derivatives
Authors: Wei Wang, Di Xiao, Sichun Zhou, Simeng Xu, Xinyi Tang, Xinchong Zhou, Jinbing Liu, Cangcang Xu, Mei Peng and Xiaoping YangBackground: In recent years, the anticancer effects of biguanide drugs have received considerable attention. However, the effective concentration of biguanide drugs to kill cancer cells is relatively high. Thus, we focus on structural modification of biguanides to obtain better antitumor candidates. A previous study in our laboratory has found that a biguanide compound containing the n-heptyl group has potent anticance Read More
-
-
-
Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7
Authors: Eman F. Abdelhaleem, Asmaa E. Kassab, Hala B. El-Nassan and Omneya M. KhalilBackground: Breast cancer is currently the leading cause of worldwide cancer incidence exceeding lung cancer. In addition, breast cancer accounts for 1 in 4 cancer cases and 1 in 6 cancer deaths among women. Cytotoxic chemotherapy is still the main therapeutic approach for patients with metastatic breast cancer. Objective: The aim of the study was to synthesize a series of novel celecoxib analogues to evaluate their antic Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/mc
Journal
10
5
false
en
